Dr. Nathan Rudemiller

Dr. Nathan Rudemiller earned his PhD in Physiology from the Medical College of Wisconsin before completing a 2-year postdoctoral fellowship at Duke University. During his postdoc, he investigated the role of the immune system in hypertension and kidney disease. Over the course of his career, Dr. Rudemiller has authored more than 20 peer-reviewed manuscripts.

Since joining BioAgilytix in September of 2017, Dr. Rudemiller has utilized his expertise in cell-based and plate-based experimentation to develop a wide range of assays. He manages a team of scientists working on the development and validation of biomarker, potency, immunogenicity, and flow cytometric assays for large molecule biotherapeutics, cell therapies, and gene therapies. Dr. Rudemiller has specific expertise in multicolor flow cytometry.